13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001884931
Total reported value
$405.7M
$405.7M
18 檔
36.2%
In Q3 2024, Whitefort Capital Management, LP's U.S. equity holdings reached a combined market value of $405.7M, distributed across 18 disclosed stock positions.
In Q3 2024, Whitefort Capital Management, LP adopted a defensive or profit-taking posture, trimming 2 positions and completely liquidating 7 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABUS | Arbutus Biopharma CORP | Stock-Other | 22.56% | -1.12% | — | |
| 2 | 0C3 | Endeavor Group Hold-class A | Stock-Other | 13.00% | — | — | |
| 3 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 12.56% | -2.70% | — | |
| 4 | JOYY | Joyy Inc-adr | Stock-Other | 9.34% | -0.50% | +168.26% | |
| 5 | GNW | Genworth Financial Inc | Stock-Financials | 9.32% | -0.19% | +49.58% | |
| 6 | LQDA | Liquidia CORP | Stock-Other | 7.75% | — | +119.76% | |
| 7 | CORZ | Core Scientific Inc | Stock-Tech | 6.20% | — | +337.14% | |
| 8 | GSL | Global Ship Lease, Inc. | Stock-Other | 4.45% | — | — | |
| 9 | NN | Nextnav Inc | Stock-Other | 4.27% | +6.72% | -16.51% | |
| 10 | ESPR 4 11-15-25Bond | Esperion Therapeutics | Bond | 3.46% | — | — | |
| 11 | SABHLD 4 04-15-25Bond | Sabre Glbl Inc | Bond | 2.26% | — | — | |
| 12 | VATE 7.5 08-01-26 *Bond | Innovate CORP | Bond | 1.87% | — | +41.12% | |
| 13 | MHLA | Maiden Holdings, Ltd. 6.625 NT 2046 | Stock-Other | 1.65% | — | — | |
| 14 | NNAVW | Nextnav Inc | Stock-Other | 0.64% | -0.09% | EXIT | |
| 15 | VATE | Innovate CORP | Stock-Other | 0.54% | +2.18% | — | |
| 16 | OPK | Opko Health Inc | Stock-Other | 0.09% | +0.24% | -66.64% | |
| 17 | TRIB | Trinity Biotech Plc-spon Adr | Stock-Other | 0.04% | — | — | |
| 18 | AEAEW | Altenergy Acquisition -cw23 | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | 0C3 | Endeavor Group Hold-class A | +13% | NEW | New buy |
| 2 | JOYY | Joyy Inc-adr | +5.4% | +168.26% | Add |
| 3 | CORZ | Core Scientific Inc | +4.7% | +337.14% | Add |
| 4 | LQDA | Liquidia CORP | +2% | +119.76% | Add |
| 5 | GNW | Genworth Financial Inc | +1.9% | +49.58% | Add |
| 6 | VATE | Innovate CORP | +0.5% | NEW | New buy |
| 7 | VATE 7.5 08-01-26 *Bond | Innovate CORP | 0% | +41.12% | Add |
| 8 | ✓ | Lanvin Group Holdings Limite | — | EXIT | Sold out |
| 9 | AEAEW | Altenergy Acquisition -cw23 | — | — | Unchanged |
| 10 | TRIB | Trinity Biotech Plc-spon Adr | -0.1% | — | Unchanged |
| 11 | OPK | Opko Health Inc | -0.2% | -66.64% | Trim |
| 12 | NNAVW | Nextnav Inc | -0.3% | — | Unchanged |
| 13 | HCHCEUR | Innovate CORP | -0.5% | EXIT | Sold out |
| 14 | SABHLD 4 04-15-25Bond | Sabre Glbl Inc | -0.7% | — | Unchanged |
| 15 | MHLA | Maiden Holdings, Ltd. 6.625 NT 2046 | -1% | — | Unchanged |
| 16 | ESPR 4 11-15-25Bond | Esperion Therapeutics | -1.1% | — | Unchanged |
| 17 | PBI | Pitney Bowes Inc | -1.2% | EXIT | Sold out |
| 18 | CORZZ | Core Scientific Inc - 29 | -1.3% | EXIT | Sold out |
| 19 | OMEX | Odyssey Marine Exploration | -1.7% | EXIT | Sold out |
| 20 | ABUS | Arbutus Biopharma CORP | -2% | — | Unchanged |
| 21 | GSL | Global Ship Lease, Inc. | -2.1% | — | Unchanged |
| 22 | ROIV | Roivant Sciences Ltd. | -3% | — | Unchanged |
| 23 | ESPR | Esperion Therapeutics Inc | -3.2% | EXIT | Sold out |
| 24 | NN | Nextnav Inc | -3.2% | -16.51% | Trim |
| 25 | LM0C | Liberty Media Corp-liber-new | -6.2% | EXIT | Sold out |
According to official SEC Form 13F filings, Whitefort Capital Management, LP reported a total U.S. public equity portfolio value of $405.7M across 18 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ABUS, 0C3, ROIV) accounted for 36.2% of total reported equity market value during Q3 2024.
Top New Position Initiated
0C3
市值: $28.6M
Top Position Liquidated / Trimmed
LM0C
前期市值: $10.1M
During Q3 2024, Whitefort Capital Management, LP's top holdings by market value included ABUS (22.6%)、0C3 (13.0%)、ROIV (12.6%). The largest single position, ABUS, represented 22.6% of total portfolio value.
In Q3 2024, Whitefort Capital Management, LP made 16 total portfolio adjustments, initiating 2 new buys, adding to 5 positions, trimming 2 holdings, and fully liquidating 7 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.